Studies have shown that deletion of IL1R1 in hepatocytes or macrophage leads to the alleviation of liver inflammation, steatosis, and damage in mice, and the use of IL1Ra benefits patients with severe alcoholic steatohepatitis (Szabo et al., 2022). This evidence concerns the gene IL1R1 and alcoholic fatty liver disease.